 NASHVILLE, Tenn., Aug. 25, 2021 PRNewswire -- Cryoport, Inc. NASDAQ: CYRX Cryoport or the Company, a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, and Mitsubishi Logistics Corporation MLC, Japans leading pharma logistics company, today announced a multi-year strategic business alliance to create an integrated regenerative medicine supply chain partnership in Japan. 